4//SEC Filing
GRANDE ALICIA 4
Accession 0001161697-23-000646
CIK 0001369568other
Filed
Dec 28, 7:00 PM ET
Accepted
Dec 29, 5:00 PM ET
Size
9.2 KB
Accession
0001161697-23-000646
Insider Transaction Report
Form 4
GRANDE ALICIA
Chief Accounting Officer
Transactions
- Tax Payment
Common Stock, par value $0.001 per share
2023-12-27−3,410→ 55,813 total - Exercise/Conversion
Restricted Stock Units
2023-12-27−8,666→ 1,187,168 total→ Common Stock (8,666 underlying) - Exercise/Conversion
Common Stock, par value $0.001 per share
2023-12-27+8,666→ 59,223 total
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
- [F2]Shares withheld by the Registrant to satisfy applicable withholding taxes upon vesting of restricted stock units.
- [F3]Derivative securities vest in equal tranches, 1/3rd on December 27, 2023, 1/3rd on December 27, 2024 and 1/3rd on December 27, 2025.
- [F4]Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The first tranche of shares was delivered on December 27, 2023.
Documents
Issuer
CATALYST PHARMACEUTICALS, INC.
CIK 0001369568
Entity typeother
Related Parties
1- filerCIK 0001402652
Filing Metadata
- Form type
- 4
- Filed
- Dec 28, 7:00 PM ET
- Accepted
- Dec 29, 5:00 PM ET
- Size
- 9.2 KB